unknown
Stage
1
Investors
About
Enjamb Labs provides an AI-driven platform that automates and orchestrates the full drug development process, including clinical evidence synthesis, trial design, statistical programming, and regulatory submissions, all within an auditable workspace integrated with existing pharma systems.
Explore Enjamb Labs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.